GD2-Specific CAR T Cells Demonstrate Potent and Targeted Anti-Tumor Efficacy Against Melanoma In Vitro and In Vivo

Julia Philippova(Research Institute of Fundamental and Clinical Immunology), С. В. Сенников(Research Institute of Fundamental and Clinical Immunology)

Frontiers in Bioscience-Landmark

August 25, 2025

10.31083/fbl41221

Cited by 3

Related Papers

Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow

|BMC Cell Biology|2004|35

Autologous dendritic cells and activated cytotoxic T‑cells as combination therapy for breast cancer

|Oncology Reports|2019|21

Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells

|Frontiers in Immunology|2024|4

Targeting Precision in Cancer Immunotherapy: Naturally-Occurring Antigen-Specific TCR Discovery with Single-Cell Sequencing

|Cancers|2024|4